semaglutide and a1c Ozempic® Pen vs Other Type 2 Diabetes Treatments Should a second agent be

Another potential limitation is that the trials had a one-sequence crossover design, and differences in observation/exposure periods make it difficult to compare safety and tolerability profiles between treatment arms

K., Sosnowski P., Rignault-Bricard R., Hermine O., Hopfgartner G., Puka-Ziach K., Lepelletier Y., Misicka A

Regular follow-up appointments are importanttypically every 3 months if therapy is being adjusted or treatment goals aren't met, and up to every 6 months for stable patients

Patients are encouraged to report any suspected adverse reactions to Ozempic via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)